Financials

News Ideas Minds Technicals

301331 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ENWEI PHARMACEUTIC operating, investing, and financing activities

301331 free cash flow for Q1 24 is -14.53 M CNY. For 2023, 301331 free cash flow was -46.38 M CNY and operating cash flow was 87.67 M CNY.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—